Longevity News

A Bayesian conditional probability simulation framework for pre-hospital stroke transport decisions in the tenecteplase era: decision boundaries, global sensitivity, and stochastic dominance

Source: Frontiers - Health • Published: 21 Aug 2026, 00:00

A Bayesian conditional probability simulation framework for pre-hospital stroke transport decisions in the tenecteplase era: decision boundaries, global sensitivity, and stochastic dominance

An updated Bayesian simulation framework models prehospital triage tradeoffs between transfer, direct CSC transport, and mobile stroke units in the tenecteplase era.

Key Takeaways
  • Prehospital large-vessel-occlusion probability is updated from validated screening scales
  • Sobol first-order and total-effect indices decompose outcome variance over the sampled input space
  • Under the production calibration the tenecteplase paradigm reallocated 14.1% of the decision plane relative to alteplase
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthAdjunctive traditional Chinese medicine for ischemic stroke: a systematic review with structured narrative synthesis and GRADE assessment of randomized controlled trialsA structured systematic review evaluates randomized trials of specific traditional Chinese medicine formulations used alongside standard care for ischemic stroke across acute, recovery, and prevention stages.Frontiers - HealthDevelopment and Validation of a Machine Learning Model Based on Multi-Source Clinical Data for Predicting the Risk of Early Neurological Deterioration in Patients with Ischemic StrokeA study presents a clinical risk model using machine learning to predict early neurological deterioration after acute ischemic stroke for bedside risk stratification.Frontiers - HealthAdvances in Rapid ADAMTS13 Testing for Thrombotic Thrombocytopenic Purpura: A Systematic Review of Diagnostic Assays and the Role of Clinical Probability ToolsRapid-testing and clinical-score advances for diagnosing acute TTP are described, previewing a review of assays, prediction tools, and diagnostic pathways.Frontiers - HealthIntegrated CDK4/6 Inhibitor Resistance and Primary-Metastatic Discordance in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Translational Framework Focused on Invasive Ductal Carcinoma With Gastric MetastasisPresents a translational framework linking genomic resistance signatures and primary‑metastatic phenotype discordance in HR+/HER2‑ metastatic breast cancer focusing on invasive ductal carcinoma with gastric spread.